GCT President, Dr. Jeffrey Apter has recently attended two major conferences on brain health and Alzheimer’s. CTAD (Clinical Trials on Alzheimer’s Disease) took place in San Diego, 4-7 December. The attendees discussed the development of the next generation of the Alzheimer’s Disease treatments. It was followed by the ACNP (The American College of Neuropshychopharmacology) 58th annual meeting in Orlando, FL on 8-11 December, and focused on brain behavior-drug interactions and most recent advances in psychopharmacology.
Both meetings were highly successful and informative, and offered a great networking opportunity.
